Xiaofeng Dong

1.0k total citations
51 papers, 716 citations indexed

About

Xiaofeng Dong is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaofeng Dong has authored 51 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Xiaofeng Dong's work include Cancer, Hypoxia, and Metabolism (6 papers), Land Use and Ecosystem Services (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Xiaofeng Dong is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Land Use and Ecosystem Services (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Xiaofeng Dong collaborates with scholars based in China, New Zealand and United States. Xiaofeng Dong's co-authors include Jie Li, Peng Xiu, Fuhai Wang, Zongzhen Xu, Feng Liu, Jingtao Zhong, Xueying Sun, Tao Li, Ju Liu and Lichen Liu and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Cancer Research.

In The Last Decade

Xiaofeng Dong

49 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Dong China 17 235 191 162 81 78 51 716
Chenxi Hu China 18 440 1.9× 202 1.1× 214 1.3× 85 1.0× 120 1.5× 65 930
Jian Lin China 19 334 1.4× 113 0.6× 199 1.2× 44 0.5× 130 1.7× 72 1.1k
Jianping Shen China 12 259 1.1× 219 1.1× 149 0.9× 20 0.2× 78 1.0× 39 623
Qin Zhu China 18 301 1.3× 151 0.8× 105 0.6× 125 1.5× 88 1.1× 89 993
Xiaoni Liu China 15 666 2.8× 128 0.7× 363 2.2× 53 0.7× 68 0.9× 47 990
Yuefeng Wang China 17 900 3.8× 341 1.8× 97 0.6× 81 1.0× 73 0.9× 86 1.4k
Huiyuan Li China 20 464 2.0× 100 0.5× 75 0.5× 44 0.5× 51 0.7× 96 1.4k
Songlin Shi China 18 610 2.6× 89 0.5× 212 1.3× 46 0.6× 47 0.6× 69 1.0k
Xiaoyun Chen China 19 478 2.0× 105 0.5× 162 1.0× 136 1.7× 61 0.8× 57 1.0k

Countries citing papers authored by Xiaofeng Dong

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Dong more than expected).

Fields of papers citing papers by Xiaofeng Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Dong. The network helps show where Xiaofeng Dong may publish in the future.

Co-authorship network of co-authors of Xiaofeng Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Dong. A scholar is included among the top collaborators of Xiaofeng Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Dong. Xiaofeng Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yu, Zuolong, Shiyue Zhang, Jiyang Liu, & Xiaofeng Dong. (2025). Sensitive homogeneous electrochemical aptasensor for aflatoxin B1 detection enabled by integrating ultrasmall nanochannels with 2D nanoprobe and DNase I-assisted target recycling. Microchemical Journal. 220. 116599–116599. 2 indexed citations
3.
Dong, Xiaofeng, et al.. (2025). Wavelength-sorting metasurface for arbitrary monochromatic infrared beam steering. Optics & Laser Technology. 193. 114252–114252.
4.
Yan, Yu‐Chuan, Lijuan Shao, Xiong Chen, et al.. (2025). Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma. Cell Death and Disease. 16(1). 645–645. 1 indexed citations
5.
Dong, Xiaofeng, et al.. (2024). Comparative transcriptomic analysis of goose astrovirus genotype 1 and 2 in goose embryonic fibroblasts. Poultry Science. 103(12). 104347–104347. 2 indexed citations
6.
Dai, Chenjie, et al.. (2024). Narrowband Spectral-Selective Wavefront Shaping via a Fabry-Perot-Type Blazed Metagrating. Journal of Lightwave Technology. 43(3). 1322–1327. 5 indexed citations
8.
Liang, Xiayi, Duo Wang, Xiaobo Wang, et al.. (2024). Tumor microenvironment-responsive manganese-based nano-modulator activate the cGAS-STING pathway to enhance innate immune system response. Journal of Nanobiotechnology. 22(1). 535–535. 19 indexed citations
9.
Dong, Xiaofeng, et al.. (2023). Detrending moving-average cross-correlation based principal component analysis of air pollutant time series. Chaos Solitons & Fractals. 172. 113558–113558. 5 indexed citations
10.
Wang, Xinhao, et al.. (2021). Delineating an Integrated Ecological and Cultural Corridor Network: A Case Study in Beijing, China. Sustainability. 13(1). 412–412. 21 indexed citations
11.
Liang, Bin, et al.. (2021). Clinical stages of recurrent hepatocellular carcinoma: A retrospective cohort study. World Journal of Clinical Cases. 9(27). 8020–8026. 3 indexed citations
12.
Dong, Xiaofeng, Peng Xiu, Jianrong Yang, et al.. (2020). Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity. 2020. 1–15. 16 indexed citations
13.
Liang, Bin, et al.. (2019). Total laparoscopic duodenum-preserving pancreatic head resection for solid pseudopaillary neoplasm of pancreas. Medicine. 98(21). e15823–e15823. 8 indexed citations
14.
Dong, Xiaofeng, Tianqi Liu, Xu–Ting Zhi, et al.. (2018). COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment. Clinical Cancer Research. 24(13). 3204–3216. 70 indexed citations
15.
Yu, Leqian, Junjun Li, Yasuhiro Takashima, et al.. (2018). Low Cell-Matrix Adhesion Reveals Two Subtypes of Human Pluripotent Stem Cells. Stem Cell Reports. 11(1). 142–156. 31 indexed citations
16.
Wang, Xin, Jingtao Zhong, Long-Tao Yue, et al.. (2018). Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma. Journal of Cancer. 9(8). 1403–1413. 26 indexed citations
17.
Li, Tao, Jingtao Zhong, Xiaofeng Dong, et al.. (2016). Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway. Oncology Reports. 35(6). 3614–3622. 28 indexed citations
18.
Dong, Xiaofeng, Rui Li, Peng Xiu, et al.. (2014). Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways. PLoS ONE. 9(3). e92864–e92864. 39 indexed citations
19.
Zhou, Xiaojun, Jianjun Dong, Li Zhang, et al.. (2014). Hyperglycemia has no effect on development of restenosis after percutaneous transluminal angioplasty (PTA) in a diabetic rabbit model. Journal of Endocrinology. 224(2). 119–125. 7 indexed citations
20.
Xu, Zongzhen, Peng Xiu, Fuhai Wang, et al.. (2014). Integrin αvβ3 is required for cathepsin B-induced hepatocellular carcinoma progression. Molecular Medicine Reports. 11(5). 3499–3504. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026